CTOs on the Move

Becton Dickinson

www.bd.com

 
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance cellular studies and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, optimize respiratory care and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health ...
  • Number of Employees: 10K-50K
  • Annual Revenue: > $1 Billion
  • www.bd.com
  • 1 Becton Drive
    Franklin Lakes, NJ USA 07417
  • Phone: 201.847.6800

Executives

Name Title Contact Details
Richard Pierle
Chief Information Officer Profile
Scott Bruder
Chief Science and Technology Officer Profile

Similar Companies

Medtech Surgical Inc

Medtech Surgical Inc is a Newark, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioAssay Systems

BioAssay Systems is a Hayward, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NoIR Laser Company

NoIR Laser Company is a South Lyon, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Atlantic Imaging Group

Atlantic Imaging Group is a Cedar Knolls, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Osprey Medical

Osprey Medical is a medical device company incorporated in 2005 with operations based in Minnetonka, Minnesota, USA. The Company is focused on protecting patients from the harmful effects of X-ray dye (contrast) used during commonly performed angiographic imaging procedures. Its proprietary dye reduction and monitoring technologies are designed to help physicians minimize dye usage. Osprey Medical`s core technologies originated from research conducted by Dr. David Kaye at Melbourne`s Baker IDI Heart and Diabetes Institute